RecruitingNot Applicable

A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension

Denmark160 participantsStarted 2015-01-01

Plain-language summary

A prospective Danish national registry of percutaneous transluminal renal angioplasty (PTRA) in high-risk patients with renal artery stenosis selected on the basis of common national criteria, and with a common follow-up protocol for all three Danish centres offering PTRA

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. At least one of the above eligibility criteria
✓. Duplex doppler ultrasonography or renography investigations consistent with hemodynamically significant renal artery stenosis
✓. CT angiography or renal arteriography with angiographic renal artery stenosis of ≥ 70 % reduction of the luminal diameter in at least one projection

Exclusion criteria

✕. If angiography/arteriography, ultrasonography or renography is consistent with bilateral significant renal artery stenosis and only one side is treated with PTRA
✕. PTRA of a renal artery supplying a kidney which pre-PTRA handles ≤ 10% of the total kidney function (with no blockage of the renin-angiotensin system) and has a kidney size \< 7 cm (length)

What they're measuring

Changes in 24-hour ambulatory systolic and diastolic blood pressures from baseline to 24 months after PTRA in patients with 24-hour ambulatory average systolic blood pressure ≥ 150 mmHg at baseline

Timeframe: Measured 24 months post-PTRA

Trial details

NCT IDNCT02770066

SponsorUniversity of Aarhus

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-01

Contact for this trial

Mark Reinhard, PhD

+45 7845 2455 m.reinhard@dadlnet.dk

View on ClinicalTrials.gov More Renal Artery Obstruction trials